Upcoming Projects (BGNE)
Don’t see a project related to the company you care about? Create your own!
Expired Projects (BGNE)
Upcoming & Overdue Catalysts (BGNE)
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (BGNE)
Beigene's(BGNE) Phase 1b data of Zanubrutinib and Obinutuzumab in Relapsed/Refractory Follicular Lymphoma to be presented at ICML
Occurred on: Jun 20, 2019
Preliminary Results Presented from Beigene's (BGNE) Phase 1 Clinical Trial of Zanubrutinib in Chinese Patients with B-Cell Lymphoma
Occurred on: Sep 21, 2018
Strategic Initiatives (BGNE)
Leap Therapeutics (LPTX) and BeiGene (BGNE) Announce Exclusive Option and License Agreement for DKN-01 + $27 Million Equity Financing
Tickers: LPTX, BGNE
Announcement Date: Jan 03, 2020